Nobel Prize Medizin: Power microRNA Krebs bare besser heilbar? | Living & Erasing

The American researchers Victor Ambros (70) and Gary Ruvkun (72) would have won the American Medizin Nobel Prize for the analysis of the microRNA. It may be a matter of a problem with the new Krebs und Herzmedikamenten session.

Next: microRNAs are specific RNA molecules, which play an important role in the regulation of general active games. One of the things that the power of credit does is a Krebs or Herzin deficiency purchase. Other solutions that provide resistance to Krebs therapies.

Deutsche Forscher arbeiten is a medicine

Laut dem Verband der forschenden Pharmaunternehmen (vfa) work Wissenschaftler schon seit Jahren daran, new Medication When that happens, the most powerful microRNAs are brought out of the closet.

The Nobel Prize winner Victor Ambros (70), professor of Molekulare Medizin at the University of Massachusetts Medical School, and Gary Ruvkun (72), Geneticist at Harvard Medical School, who work at the Massachusetts General Hospital, will long investigate the function of microRNA investigate thoroughly. The Kurzen RNA-Stränge can reduce or block the Bildung best proteins.

Deutsche Forscher machen themselves die Nobel Prize Entdeckung it can be useful when researching new medications.

Wissenschaftler from Hannover can buy a medicine Herzinsuffizienz (2.5 Mio. Deutsche affected), the best microRNAs from the Gefecht Setzt. Der Ansatz is so veldverprechend, dass der dänische Abnehm-Spritzen-Konzern Novo Nordisk a Billionaire Deal with the Lower Saxony Biotech Start-up Cardior Pharmaceuticals power. The drug has not been studied for the symptom, but it is the hardening of the pathogens.

There is a new Ansatz in Krebstherapy

If Krebs are no longer available, microRNAs are best used as a booster for your own Krebs therapy. Jedes Jahr erkranken alleine in Deutschland fast 500 000 Menschen neu an Krebs.

US-Wissenschaftler von der Purdue Universität in West Lafayette (USA) was able to look for a job at the age of 21 Maus model the Tumor Wachstum has failed, which is the case in the untreatable control group of the Tumor in der gleichen Zeit um das Dreifache wuchs.

If the treatment takes place on the basis of the Nobel Prize Development, the drugs will be offered to patients on the market, but it may still take a few years.